ATRS Stock Price, Chart, Stats & News

Antares Pharma, Inc.
Save
–
Market cap
14.95x
Current P/E
–
Forward P/E
ATRS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 62.89% |
Operating margin | 33.85% |
Pretax margin | 33.85% |
Net margin | 25.16% |
Effective tax rate | 25.67% |
ROA | 17.98% |
ROE | 31.40% |
D/E | 0.14x |
Interest coverage ratio | – |
ATRS valuation
P/E | 14.95x |
P/S | – |
P/B | 5.41x |
P/CF | 25.97x |
P/FCF | – |
P/OCF | 25.97x |
PEG | 0.21x |
EV multiple | 0.63x |
About
Antares Pharma, Inc. operates as a specialized pharmaceutical enterprise, primarily dedicated to innovating and marketing medicines and advanced technologies. Its core mission is to address critical patient needs across a range of therapeutic areas. The company achieves this by developing, manufacturing, and commercializing groundbreaking therapeutic products, often leveraging its distinctive drug delivery systems.
Similar securities
Based on sector and market capitalization
Report issue











